Yrab 20mg Tablet contains Rabeprazole 20mg, a proton pump inhibitor (PPI) used to reduce gastric acid secretion. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system located on the gastric parietal cell surface, thereby suppressing the final step in acid production. This medication is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease, including Helicobacter pylori eradication as part of combination therapy. Yrab 20mg is effective in relieving symptoms such as heartburn, acid regurgitation, and gastric discomfort by promoting mucosal healing and reducing acid-related damage. The tablet is generally well tolerated; common adverse effects may include headache, diarrhea, nausea, and abdominal pain. It is contraindicated in patients with known hypersensitivity to Rabeprazole or other PPIs. Caution is advised in patients with severe liver impairment. Yrab 20mg should be administered orally, preferably before meals, once daily or as directed by a healthcare professional. Long-term use requires monitoring for potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Patients should consult their physician before initiating or discontinuing therapy.